Abstract
We report a case of inadvertent hoarseness after surgery for primary pulmonary amyloidosis. A 55-year-old male was transferred to our facility due to a lung mass. Chest computed tomography revealed a solitary pulmonary nodule. Positron emission tomography–computed tomography showed fluorodeoxyglucose uptake in the main mass and in the mediastinal lymph nodes. To confirm the pathology of the mass, wedge resection and thorough lymph node dissection were performed via video-assisted thoracic surgery (VATS). No complications except for hoarseness were observed; hoarseness developed soon after surgery and lasted for 3 months. The main mass was diagnosed as amyloidosis, but this was not found in the lymph nodes. In conclusion, VATS wedge resection for peripheral amyloidosis is a feasible and safe procedure. However, mediastinal lymph node dissection is not recommended unless there is evidence of a clear benefit.
Keywords: Solitary pulmonary nodule, Amyloidosis, Video-assisted thoracic surgery
CASE REPORT
Primary pulmonary amyloidosis is a rare disease that can be mistaken for lung cancer [1]. Although percutaneous lung biopsy and other diagnostic modalities including positron emission tomography–computed tomography (PET-CT) can be helpful, surgical resection is required to determine the exact pathologic diagnosis [2]. Subaortic lymph nodes in particular are difficult to investigate without surgery. We herein report a case of primary pulmonary amyloidosis with mediastinal lymphadenopathy and inadvertent postoperative complications.
A 55-year-old man was transferred to the department of thoracic surgery due to a solitary pulmonary nodule in the left lower lobe (Fig. 1A). The nodule was found 3 months prior and had increased in size on follow-up chest CT, implying lung cancer. PET-CT showed subtle fluorodeoxyglucose uptake in the pulmonary nodule, but strong uptake in the mediastinal lymph node (Fig. 1B). A percutaneous lung biopsy was performed, but the results were insufficient for diagnosis. Therefore, video-assisted thoracic surgery (VATS) was performed. The pulmonary nodule was located in a major fissure and was found easily. Wedge resection was performed and the cut edge of the mass showed grayish tan-colored, firm features. The subaortic lymph node was located deep under the aorta, and careful dissection was performed to avoid injury to the vagus or recurrent laryngeal nerve (Fig. 2). Electrocautery was also limited in order to avoid thermal injury. Lymph node sampling was attempted, but thorough dissection was unavoidable because massive bleeding occurred along the cut edge of the lymph node. There were no postoperative complications, with the exception of hoarseness. Although vocal symptoms improved upon follow-up in the outpatient clinic, vocal cord palsy was still observed on postoperative day 90. In pathologic reports, amorphous eosinophilia and positive Congo red staining were found in the pulmonary nodule, consistent with amyloidosis (Fig. 3). Lymph involvement of amyloidosis was not found, but reactive hyperplasia was observed in all mediastinal lymph nodes. Further diagnostic tests to rule out systemic diseases that could lead to secondary amyloidosis (e.g., multiple myeloma) were performed. All blood tests with light chain lambda, kappa, beta 2-microglobulin, and protein electrophoresis in serum and urine were within normal limits. However, a brain magnetic resonance imaging was not performed due to patient refusal. The nodule was diagnosed as primary pulmonary amyloidosis, and regular follow-up was planned without additional treatment.
Fig. 1.
Chest CT and PET-CT of the main mass (*) and mediastinal lymph nodes (!). (A) Solitary pulmonary nodule in the left lower lobe on chest CT. (B) Pulmonary nodule and mediastinal lymphadenopathy on PET-CT. CT, computed tomography; PET, positron emission tomography.
Fig. 2.
Operative view for subaortic lymph node dissection. The subaortic lymph node was dissected completely.
Fig. 3.
Amorphous eosinophilia and positive Congo red staining were found in the pulmonary nodule. (A) H&E stain, ×400. (B) Congo red stain, ×400.
DISCUSSION
Primary pulmonary amyloidosis is a rare disease characterized by the deposition of immunoglobulin light-chain fragments [3]. Intrathoracic manifestations are broad, including tracheobronchial, parenchymal, and pleural involvement in addition to mediastinal lymphadenopathy [2,4]. Pulmonary amyloidosis can be associated with lymphoproliferative diseases such as mucosa-associated lymphoid tissue lymphoma or multiple myeloma [5]. Percutaneous lung biopsy is typically sufficient for pathological diagnosis [1,6], but surgical resection is recommended when malignancy is suspected [2,7].
Excision of the lesion is the treatment of choice due to its rare recurrence [4]. However, it remains unclear whether lymph node dissection is necessary. According to this report, lymph node dissection may be harmful in primary pulmonary amyloidosis. Mediastinal lymphadenopathy is not a rare condition in the disease entity, but mediastinal involvement by amyloidosis is rare [8]. Careful subaortic lymph node dissection was performed, but it resulted in hoarseness lasting for 3 months. Moreover, there was no pathologic evidence that the lymph nodes were involved in amyloidosis. Therefore, mediastinal sampling or biopsy is recommended over thorough dissection in the case of primary pulmonary amyloidosis.
In conclusion, treating peripheral amyloidosis with VATS wedge resection can be an effective option, but mediastinal lymph node dissection should be done carefully.
Footnotes
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
REFERENCES
- 1.Dong MJ, Zhao K, Liu ZF, Wang GL, Yang J. Primary pulmonary amyloidosis misdiagnosed as malignancy on dual-time-point fluoro-deoxyglucose positron emission tomography/computed tomography: a case report and review of the literature. Oncol Lett. 2015;9:591–4. doi: 10.3892/ol.2014.2778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Eguchi T, Yoshida K, Kobayashi N, et al. Localized nodular amyloidosis of the lung. Gen Thorac Cardiovasc Surg. 2011;59:715–7. doi: 10.1007/s11748-010-0748-y. [DOI] [PubMed] [Google Scholar]
- 3.Jeon DH, Lee CS, Cho SR, Kim YO. Pulmonarg nodular amyloidosis. Korean J Thorac Cardiovasc Surg. 1999;32:1060–3. [Google Scholar]
- 4.Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996;124:407–13. doi: 10.7326/0003-4819-124-4-199602150-00004. [DOI] [PubMed] [Google Scholar]
- 5.Cordier JF. Pulmonary amyloidosis in hematological disorders. Semin Respir Crit Care Med. 2005;26:502–13. doi: 10.1055/s-2005-922033. [DOI] [PubMed] [Google Scholar]
- 6.Yong HS, Woo OH, Lee JW, Suh SI, Oh YW, Kang EY. Primary localized amyloidosis manifested as supraclavicular and mediastinal lymphadenopathy. Br J Radiol. 2007;80:e131–3. doi: 10.1259/bjr/52539691. [DOI] [PubMed] [Google Scholar]
- 7.Seo JH, Lee SW, Ahn BC, Lee J. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer. 2010;67:376–9. doi: 10.1016/j.lungcan.2009.11.014. [DOI] [PubMed] [Google Scholar]
- 8.Takeshita K, Yamada S, Sato N, et al. An unusual case of mediastinal lymphadenopathy caused by amyloidosis. Intern Med. 2000;39:839–42. doi: 10.2169/internalmedicine.39.839. [DOI] [PubMed] [Google Scholar]



